- Director, Stroke Center, Neurological Institute, University Hospitals
- Chair, Department of Neurology, UH Cleveland Medical Center
- Professor, CWRU School of Medicine Gilbert W Humphrey Endowed Chair in Neurology
- Inaugural Distinguished Senior Attending Physician, University Hospitals
Cathy Sila MD, FAAN, FAHA is the Chair of the Department of Neurology at University Hospitals and Case Western Reserve University School of Medicine. She holds the Gilbert W Humphrey Endowed Chair in Neurology and was the first Distinguished Senior Attending Physician in Neurology at University Hospitals. Dr. Sila previously served as the Vice Chair in the Department of Neurology for Clinical Activities & Quality and directs the University Hospitals System Stroke Program, which is recognized as a model of system integration for health care delivery.
Dr. Sila is a recognized expert in preventing and treating stroke, neurologic complications of heart disease, and defining outcomes for clinical trials. As the first woman to chair neurology at UH, her priorities include ensuring access to innovative, high-value care integrated throughout the health system, supporting the provider-patient relationship and experience, training the next generation through the many fellowships and one of the largest neurology residency programs in the country, and promoting research that improves the quality of life for patients with neurologic diseases.
Dr. Sila received undergraduate degrees in Chemistry and Zoology and graduated from Case Western Reserve University School of Medicine. She completed her Neurology residency at the Mayo Clinic, followed by Fellowship training in Cerebrovascular Research at the Cleveland Clinic. She has extensive clinical research and research administration and core lab experience for more than 100 clinical trials, data element developer for the FDA and NINDS, and expert panel advisor for emerging technologies and therapeutics.
Dr. Sila has received numerous honors, elected to AHA/ASA and AAN executive committees, and was appointed to national directorship and institutional leadership boards. She has received awards from the American Heart Association National Stroke Council, YWCA Women of Professional Excellence, and Crain's Cleveland Business Healthcare Hero. She is consistently named among America's Top Doctors by Castle-Connelly and is one of their Exceptional Women in Medicine.
- Carotid Artery Disease
- Carotid Artery Dissection
- Cerebral Vasculitis
- Intracranial Stenosis
- Patent Foramen Ovale (PFO)
- Stroke in the Young
- Stroke Prevention
- Transient Ischemic Attack (TIA)
- Vascular Neurology
- Vertebral Artery Dissection
Research & Publications
Clinical Trials Design, Administration, & Clinical Events Adjudication | Cerebrovascular Complications of Cardiovascular Tests & Procedures | Stroke Systems of Care
Certifications & Memberships
- Vascular Neurology - American Board of Psychiatry and Neurology
- Neurology - American Board of Psychiatry and Neurology
Fellowship | Cerebrovascular
Cerebrovascular - Cleveland Clinic (1985 - 1986)
Residency | Neurology
Neurology - Mayo Clinic College Of Medicine And Science (1983 - 1985)
Residency | Neurology
Neurology - Cleveland Clinic (1982 - 1983)
Internship | Internal Medicine
Internal Medicine - Cleveland Clinic (1981 - 1982)
Case Western Reserve University School Of Medicine (1981)
Miami University (1977)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Cathy Sila disclosed the following Outside Relationships with Industry:
- - Hoffman LaRoche - Consulting
- - Monteris Medical, Inc. - Ownership